INVEX Therapeutics Ltd (IXC)
IXC Chart
IXC's Principal Activity is the biopharmaceuticals.
Share Price Activity
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2021 YTD | |
| 1 Year | |
| vs Sector (1yr) | -46.23% |
| vs ASX 200 (1yr) | -59.71% |
Size
| Market Capitalisation | |
| ASX Rank | 1,331 of 2,295 |
| Sector Rank | 115 of 177 |
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Company Overview
Invex Therapeutics Ltd (IXC) is a biopharmaceutical company focused on the repurposing of an approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. Invex has trademarked its repurposed Exenatide as Presendin.
Incorporation Details
No incorporation details available.
Corporate Details
| Head Office | Subiaco WA 6008 |
| Website | www.invextherapeutics.com |
| Registry | Automic Group |
| Auditor | BDO Audit (WA) Pty Ltd |
| Date Listed | 5 Jul 2019 |
Upcoming Calendar (Forecasted)
| Date | Event |
|---|---|
| 27/08/2021 | Report (Prelim) |
| 27/08/2021 | Report (Annual) |
| 14/02/2022 | Report (Interim) |
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors & Management
Director Transactions
IXC directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of IXC directors.
Shareholder Info
Top 20 Shareholders About the Data
Data supplied by Morningstar and accurate on Aug 27, 2020.
It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.
All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).
Shareholder Distribution
As reported in the most recent Annual Report.
| Holding Size | 1 - 1,000 | 1,001 - 5,000 | 5,001 - 10,000 | 10,001 - 100,000 | 100,001+ | Total |
|---|---|---|---|---|---|---|
| No. of Shareholders | 274 | 416 | 184 | 357 | 86 | 1,317 |
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
| Name | Last Notice | Total Shares | Shares Held (%) |
|---|---|---|---|
| Tattarang Pty Ltd | 27/08/2020 | 8,846,154 | 11.77 |
| Tisia Nominees Pty Ltd | 27/08/2020 | 4,000,000 | 5.32 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
| Date | Name | Sold | Previous % | New % |
|---|---|---|---|---|
| 01-12-20 | JK Nominees Pty Ltd | 4,000,000 | 5.92 | -- |
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2020 | $1.30 | 30 June |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.